Egawa H, Teramukai S, Haga H, Tanabe M, Mori A, Ikegami T, et al. Impact of rituximab desensitization on blood-type-incompatible adult living donor liver transplantation: a Japanese multicenter study. Am J Transplant. 2014;14(1):102–14.

CAS  PubMed  Google Scholar 

Raut V, Uemoto S. Management of ABO-incompatible living-donor liver transplantation: past and present trends. Surg Today. 2011;41(3):317–22.

CAS  PubMed  Google Scholar 

Hirukawa K, Shinoda M, Hasegawa Y, Obara H, Kitago M, Yagi H, et al. Long-term outcomes following ABO-incompatible living donor liver transplantation for acute liver failure: a single-center experience of over 20 years. Surg Today. 2023;53(10):1160–72.

CAS  PubMed  Google Scholar 

Egawa H. Challenge to ABO blood type barrier in living donor liver transplantation. Hepatobiliary Pancreat Dis Int. 2020;19(4):342–8.

CAS  PubMed  Google Scholar 

Tanabe M, Shimazu M, Wakabayashi G, Hoshino K, Kawachi S, Kadomura T, et al. Intraportal infusion therapy as a novel approach to adult ABO-incompatible liver transplantation. Transplantation. 2002;73(12):1959–61.

PubMed  Google Scholar 

Ikegami T, Taketomi A, Soejima Y, Yoshizumi T, Uchiyama H, Harada N, et al. Rituximab, IVIG, and plasma exchange without graft local infusion treatment: a new protocol in ABO incompatible living donor liver transplantation. Transplantation. 2009;88(3):303–7.

CAS  PubMed  Google Scholar 

Usui M, Isaji S, Mizuno S, Sakurai H, Uemoto S. Experiences and problems pre-operative anti-CD20 monoclonal antibody infusion therapy with splenectomy and plasma exchange for ABO-incompatible living-donor liver transplantation.

Egawa H, Ohdan H, Saito K. Current status of ABO-incompatible liver transplantation. Transplantation. 2023;107(2):313–25.

CAS  PubMed  Google Scholar 

Umeshita K, Eguchi S, Egawa H, Haga H, Kasahara M, Kokudo N, et al. Liver transplantation in Japan: Registry by the Japanese Liver Transplantation Society. Hepatol Res. 2019;49(9):964–80.

PubMed  Google Scholar 

Paterno F, Shiller, Tillery MG, O’Leary JG, Susskind B, Trotter J, et al. Bortezomib for acute antibody-mediated rejection in liver transplantation. Am J Transplant. 2012;12(9):2526–31.

CAS  PubMed  PubMed Central  Google Scholar 

Yamamoto H, Uchida K, Kawabata S, Isono K, Miura K, Hayashida S, et al. Feasibility of monotherapy by rituximab without additional desensitization in ABO-incompatible living-donor liver transplantation. Transplantation. 2018;102(1):97–104.

CAS  PubMed  Google Scholar 

Soejima Y, Muto J, Matono R, Ninomiya M, Ikeda T, Yoshizumi T, et al. Strategic breakthrough in adult ABO-incompatible living donor liver transplantation: preliminary results of consecutive seven cases. Clin Transplant. 2013;27(2):227–31.

PubMed  Google Scholar 

Raut V, Mori A, Kaido T, Ogura Y, Taku I, Nagai K, et al. Splenectomy does not offer immunological benefits in ABO-incompatible liver transplantation with a preoperative rituximab. Transplantation. 2012;93(1):99–105.

CAS  PubMed  Google Scholar 

Ikegami T, Taketomi A, Soejima Y, Iguchi T, Sanefuji K, Kayashima H, et al. Successful ABO incompatible living donor liver transplantation in a patient with high isoagglutinin titer using high-dose intravenous immunoglobulin. Transplant Proc. 2007;39(10):3491–4.

CAS  PubMed  Google Scholar 

Shen T, Lin BY, Jia JJ, Wang ZY, Wang L, Ling Q, et al. A modified protocol with rituximab and intravenous immunoglobulin in emergent ABO-incompatible liver transplantation for acute liver failure. Hepatobiliary Pancreat Dis Int. 2014;13(4):395–401.

CAS  PubMed  Google Scholar 

Jolles S. A review of high-dose intravenous immunoglobulin (hdIVIg) in the treatment of the autoimmune blistering disorders. Clin Exp Dermatol. 2001;26(2):127–31.

CAS  PubMed  Google Scholar 

Hughes RA, Swan AV, van Doorn PA. Intravenous immunoglobulin for Guillain-Barre syndrome. Cochrane Database Syst Rev. 2014;2014(9):CD002063.

PubMed  PubMed Central  Google Scholar 

Ferrero B, Durelli L. High-dose intravenous immunoglobulin G treatment of myasthenia gravis. Neurol Sci. 2002;23(Suppl 1):S9-24.

PubMed  Google Scholar 

Bellière J, Rostaing L, Guilbeau-Frugier C, Congy N, Kamar N. Low- versus high-dose rituximab for antibody-mediated rejection after kidney transplantation. Transpl Int. 2013;26(2):e12–4.

PubMed  Google Scholar 

Cengiz Seval G, Beksac M. The safety of bortezomib for the treatment of multiple myeloma. Expert Opin Drug Saf. 2018;17(9):953–62.

CAS  PubMed  Google Scholar 

Lee WC, Cheng CH, Lee CF, Hung HC, Lee JC, Wu TH, et al. Quick preparation of ABO-incompatible living donor liver transplantation for acute liver failure. Clin Transplant. 2022;36(3): e14555.

CAS  PubMed  Google Scholar 

Valamparampil JJ, Sachan D, Shanmugam N, Reddy SM, Rela M. Emergency ABO-incompatible living donor liver transplantation in Wilson disease-induced acute liver failure. Case Reports Asian J Transfus Sci. 2023;17(1):128–30.

PubMed  Google Scholar 

Haga H, Egawa H, Shirase T, Miyagawa A, Sakurai T, Minamiguchi S, et al. Periportal edema and necrosis as diagnostic histological features of early humoral rejection in ABO-incompatible liver transplantation. Liver Transpl. 2004;10(1):16–27.

PubMed  Google Scholar